Recruiting

Cardiovascular Monitoring

Sponsor:

Mayo Clinic

Code:

NCT07224685

Conditions

Cardiovascular Diseases

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Interventions

Voice Recording

Study Details

Brief summary:

The purpose of the study is to determine whether voice recordings acquired from patient-owned Android and Apple (iOS) smartphones can be used to monitor cardiovascular health. Voice signals will be processed to determine whether we can detect presence of cardiovascular disease and wellness, or if health risks exist.

Conditions

Cardiovascular Diseases

Study ID

NCT07224685

Start date

Mar 5, 2024

Status verified date

Oct, 2025

Completion date

Mar, 2029

Anticipated

Primary completion date

Mar, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Adult patients using the Mayo patient iPhone app and iOS 14.0 or later (determined automatically via Mayo software) and Apple Watch v 4 or later (not SE), or if they have Android device for voice
  • Expressed interest in participation
  • Signed HIPPA authorization

Exclusion Criteria:

• Age under 18

Study Design

Enrollment

1000000 participants

Anticipated

Interventions and Outcome Measures

Arms

Adult patients using the Mayo patient iPhone app

Interventions

Voice Recording

Patients will record a 30-second to 2-minute video pronouncing vowel sounds or reading a short script. This will occur every 14 days for up to five years.

Primary outcome measure

  • Total Patients Who Recorded a Voice Sample [ Time Frame: Baseline ]

Central Contacts and Locations

Central contacts

Locations

Mayo Clinic in Rochester

Recruiting

Rochester, Minnesota, United States, 55905

Contacts

Principal Investigator:

Paul Friedman, MD

More Information

Sponsor

Mayo Clinic

Last update posted

Nov 5, 2025

Last verified

Oct, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Mayo Clinic on 2025-11-05.